Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Our experience serving more than 1.7M subscribers 1 , combined with our infrastructure, gives us confidence that this is the best time to begin offering access to GLP-1s
It is frustrating to us as Patient Advocates that initial evidence relied on was not at that time suitably researched or understood and now, 30 years on, of course, we know so much more
Mazdutide, a dual glucagon and GLP-1 agonist, is approved
TB-500 is a synthetic fragment of TB4 that is also found on the peptide market
Clinical data shows that discontinuing either semaglutide or tirzepatide leads to significant weight regain in most users, often recovering two-thirds of the lost weight within one year of stopping
Potential for Additive or Synergistic Effects: The primary research question would be whether the combination yields truly synergistic effects beyond what each peptide achieves alone
